Protective effects of (1-(4-hydroxy-phenyl)-3-m-tolyl-propenone chalcone in indomethacin-induced gastric erosive damage in rats

BMC Veterinary Research

Volumn 10, Issue 1, 2014, Pages

  Dhiyaaldeen, Summaya M ^a   Amin, Zahra A ^b   Darvish, Pouya H ^a   Mustafa, Iman Fahmi ^a   Jamil, Mazen M ^c   Rouhollahi, Elham ^a   Abdulla, Mahmood A ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b HAWLER MEDICAL UNIVERSITY   (Iraq)

^c UNIVERSITI TEKNOLOGI MARA   (Malaysia)

Author keywords

Antioxidant; Chalcone; Endogenous enzymes; Histology; Immunohistochemistry; Indomethacin; Peptic ulcer

Indexed keywords

1-(4-HYDROXYPHENYL)-3-M-TOLYLPROPENONE; ANTIULCER AGENT; CHALCONE DERIVATIVE; INDOMETACIN; LIPID; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; FEMALE; KIDNEY; LIVER; MALE; PEPTIC ULCER; RAT; SPRAGUE DAWLEY RAT; STOMACH MUCOSA;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; CHALCONES; FEMALE; GASTRIC MUCOSA; INDOMETHACIN; KIDNEY; LIPIDS; LIVER; MALE; PEPTIC ULCER; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84924065092     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/s12917-014-0303-7     Document Type: Article

References (36)

1. Sung JJ, Kuipers EJ, El-Serag HB: Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther 2009, 29(9):938-946.
2. Suzuki RB, Cola RF, Cola LT, Ferrari CG, Ellinger F, Therezo AL, Silva LC, Eterovic A, Speranca MA: Different risk factors influence peptic ulcer disease development in a Brazilian population. World J Gastroenterol 2012, 18(38):5404-5411.
3. Levenstein S, Kaplan GA: Socioeconomic status and ulcer. A prospective study of contributory risk factors. J Clin Gastroenterol 1998, 26(1):14-17.
4. Chan FK, Abraham NS, Scheiman JM, Laine L: Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents. Am J Gastroenterol 2008, 103(11):2908-2918.
5. Yuan Y, Padol IT, Hunt RH: Peptic ulcer disease today. Nat Clin Pract Gastroenterol Hepatol 2006, 3(2):80-89.
6. Takeuchi K: Pathogenesis of NSAID-induced gastric damage: importance of cyclooxygenase inhibition and gastric hypermotility. World J Gastroenterol 2012, 18(18):2147.
7. Salga MS, Ali HM, Abdullah MA, Abdelwahab SI, Hussain PD, Hadi AHA: Mechanistic studies of the anti-ulcerogenic activity and acute toxicity evaluation of dichlorido-copper (II)-4-(2-5-Bromo-benzylideneamino) ethyl) piperazin-1-ium phenolate complex against ethanol-induced gastric injury in rats. Molecules 2011, 16(10):8654-8669.
8. Gwaram NS, Ali HM, Abdulla MA, Buckle MJ, Sukumaran SD, Chung LY, Othman R, Alhadi AA, Yehye WA, Hadi AHA: Synthesis, Characterization, X-ray crystallography, acetyl cholinesterase inhibition and antioxidant activities of some novel ketone derivatives of gallic hydrazide-derived schiff bases. Molecules 2012, 17(3):2408-2427.
9. Golbabapour S, Gwaram NS, Hassandarvish P, Hajrezaie M, Kamalidehghan B, Abdulla MA, Ali HM, Hadi AHA, Majid NA: Gastroprotection studies of Schiff base zinc (II) derivative complex against acute superficial hemorrhagic mucosal lesions in rats. PloS one 2013, 8(9):e75036.
10. Malfertheiner P, Chan FK, McColl KE: Peptic ulcer disease. Lancet 2009, 374(9699):1449-1461.
11. Bashinskaya B, Nahed BV, Redjal N, Kahle KT, Walcott BP: Trends in Peptic Ulcer Disease and the Identification of Helicobacter Pylori as a Causative Organism: Population-based Estimates from the US Nationwide Inpatient Sample. J Glob Infect Dis 2011, 3(4):366-370.
12. Al Mofleh IA: Spices, herbal xenobiotics and the stomach: Friends or foes? World J Gastroenterol 2010, 16(22):2710.
13. Parmar NS, Parmar S: Anti-ulcer potential of flavonoids. Indian J Physiol Pharmacol 1998, 42(3):343-351.
14. Mota KSL, Dias GEN, Pinto MEF, Luiz-Ferreira Â, Monteiro Souza-Brito AR, Hiruma Lima CA, Barbosa Filho JM, Batista LM: Flavonoids with Gastroprotective Activity. Molecules 2009, 14(3):979-1012.
15. Padhye S, Ahmad A, Oswal N, Sarkar FH: Emerging role of Garcinol, the antioxidant chalcone from Garcinia indica Choisy and its synthetic analogs. J Hematol Oncol 2009, 2:38.
16. Kim MJ, Lee YH, Kwak J, Na Y, Yoon HG: Protective effects of a chalcone derivative against Abeta-induced oxidative stress and neuronal damage. BMB Rep 2011, 44(11):730-734.
17. Batovska DI, Todorova IT: Trends in utilization of the pharmacological potential of chalcones. Curr Clin Pharmacol 2010, 5(1):1-29.
18. Kyogoku K, Hatayama K, Yokomori S, Saziki R, Nakane S, Sasajima M, Sawada J, Ohzeki M, Tanaka I: Anti-ulcer effect of isoprenyl flavonoids. II. Synthesis and anti-ulcer activity of new chalcones related to sophoradin. Chem Pharmaceut Bull 1979, 27(12):2943.
19. Ketuly KA, Hadi AHA, Golbabapour S, Hajrezaie M, Hassandarvish P, Ali HM, Majid NA, Abdulla MA: Acute toxicity and gastroprotection studies with a newly synthesized steroid. PloS One 2013, 8(3):e59296.
20. Odabasoglu F, Cakir A, Suleyman H, Aslan A, Bayir Y, Halici M, Kazaz C: Gastroprotective and antioxidant effects of usnic acid on indomethacin-induced gastric ulcer in rats. J Ethnopharmacol 2006, 103(1):59-65.
21. Carrasco-Pozo C, Speisky H, Brunser O, Pastene E, Gotteland M: Apple peel polyphenols protect against gastrointestinal mucosa alterations induced by indomethacin in rats. J Agric Food Chem 2011, 59(12):6459-6466.
22. Hollander F: The two-component mucous barrier: its activity in protecting the gastroduodenal mucosa against peptic ulceration. Arch Intern Med 1954, 93(1):107.
23. Nair S, Norkus EP, Hertan H, Pitchumoni C: Micronutrient antioxidants in gastric mucosa and serum in patients with gastritis and gastric ulcer: does Helicobacter pylori infection affect the mucosal levels? J Clin Gastroenterol 2000, 30(4):381-385.
24. Koizumi S, Odashima M, Otaka M, Jin M, Linden J, Watanabe S, Ohnishi H: Attenuation of gastric mucosal inflammation induced by indomethacin through activation of the A2A adenosine receptor in rats. J Gastroenterol 2009, 44(5):419-425.
25. Abdel-Raheem IT: Gastroprotective effect of rutin against indomethacin-induced ulcers in rats. Basic Clin Pharmacol Toxicol 2010, 107(3):742-750.
26. Indran M, Mahmood AA, Kuppusamy UR: Protective effect of Carica papaya L leaf extract against alcohol induced acute gastric damage and blood oxidative stress in rats. West Indian Med J 2008, 57(4):323-326.
27. Okunrobo LO, Usifoh CO, Uwaya JO: Anti-inflammatory and gastroprotective properties of some chalcones. Acta Pol Pharm 2006, 63:195-199.
28. Shin JM, Munson K, Sachs G.: Gastric H+, K+-ATPase. Compr Physiol. 2011
29. Abe K, Tani K, Fujiyoshi Y: Conformational rearrangement of gastric H+, K + -ATPase induced by an acid suppressant. Nat Comm 2011, 2:155.
30. Elahi M, Inayat Q, Wazir F, Huma Z: Adaptation of Rat Gastric Mucosa exposed to Indomethacin: A Histological Study. Gomal J Med Sci 2009, 7(2):231-238.
31. OECD: Acute oral toxicity-Acute toxic class method, Volume 423. Paris: OECD; 1996.
32. Abdelwahab SI, Taha MME, Abdulla MA, Nordin N, Hadi AHA, Mohan S, Jayapalan JJ, Hashim OH: Gastroprotective mechanism of Bauhinia thonningii Schum. J Ethnopharmacol 2013, 1:277-286.
33. Fox JG, Anderson LC, Loew FM, Quimby FW: Laboratory animal medicine: Academic press; 2002
34. Wasman S, Mahmood A, Chua LS, Alshawsh MA, Hamdan S: Antioxidant and gastroprotective activities of Andrographis paniculata (Hempedu Bumi) in Sprague Dawley rats. 2011
35. Corne SJ, Morrissey SM, Woods RJ: Proceedings: A method for the quantitative estimation of gastric barrier mucus. J Physiol 1974, 242(2):116P-117P.
36. McManus J, Mowry R: PAS reaction staining. Harpoer & Row, New York: A Hoeber International Reprint; 1964.